Filter Results :

Your search for Therapies returned 68 reports

Sort by


Calcitonin - Gene Related Peptide (CGRP) Antagonists /Monoclonal Antibodies: New Targeted Therapies for Migraine

12 Feb 2018  |  Published by:  ProGrow Pharma Partners
Migraine has been recognized as a highly disabling neurological pain disorder and its management is often challenging! Despite it being more prevalent than diabetes, epilepsy and asthma combined, efficacious drugs for treating migraine are still wanting.  Better drugs for diabetes and asthma ha...

$ 2,500.00

Read More

Advanced Inhalation Therapies (AIT) Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

31 Jan 2018  |  Published by:  GlobalData
SummaryAdvanced Inhalation Therapies (AIT) Ltd (AIT), formerly KokiCare Inc is a provider of chronic disease management solutions. The company develops products for bronchiolttis, MABSC, chronic obstructive pulmonary disease, diabetic foot ulcers, stroke and cystic fibrosis. It develops proprietary ...

$ 250.00

Read More

Global Allergy Immunotherapies Industry Market Analysis & Forecast 2018-2023

03 Jan 2018  |  Published by:  S&P Consulting
In the Global Allergy Immunotherapies Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is fo...

$ 3,800.00

Read More

Global Hyperglycemia Medicines Market (By Product- Injectable Drugs, Oral Drugs, Insulin Pumps, Insulin Therapies, Insulin Injection Devices and Others. By Application- Type I Diabetes, Type II Diabetes and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

01 Jan 2018  |  Published by:  Sheer Analytics & Insights
The report covers the analysis and forecast of the hyperglycemia medicines market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).The study provides a detailed view of the hyperglycem...

$ 4,795.00

Read More

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis

01 Jan 2018  |  Published by:  GBI Research
Summary“Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” discusses all gene therapies, including not only those which involve genetic modification, but also RNAi, CAR-T...

$ 2,995.00

Read More

Global Anti-Aging Products and Therapies Market Research Report 2017

30 Dec 2017  |  Published by:  9Dimen Research
Anti-Aging Products and Therapies Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Uni...

$ 2,850.00

Read More

Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile

22 Dec 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 250.00

Read More

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

15 Dec 2017  |  Published by:  GBI Research
SummaryThe genetic disorders therapy area consists of indications that arise because of an abnormality in a person’s DNA. This report focuses on the key therapy area indications of cystic fibrosis (CF), Duchenne muscular dystrophy (DMD), lysosomal storage disease (LSD) and paroxysmal nocturnal hemog...

$ 4,995.00

Read More

AZTherapies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

13 Dec 2017  |  Published by:  GlobalData
SummaryAZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer's disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the lea...

$ 250.00

Read More

COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

01 Dec 2017  |  Published by:  GBI Research
SummaryChronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most often in older people, but can also affect the middle aged population. COPD is a major cause of c...

$ 4,995.00

Read More

Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 Nov 2017  |  Published by:  GlobalData
SummaryVital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute li...

$ 250.00

Read More

Biotie Therapies Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 Nov 2017  |  Published by:  GlobalData
SummaryBiotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinson's disease, alzheimer's disease, pri...

$ 250.00

Read More

BioRestorative Therapies Inc (BRTX) - Medical Equipment - Deals and Alliances Profile

27 Nov 2017  |  Published by:  GlobalData
SummaryBioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment ...

$ 250.00

Read More

Therapies for Resistant and Recurrent Metastatic Cancer

06 Nov 2017  |  Published by:  BCC Research
The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.Report Includes-84 data tables and 46 additional tables-An overview of the market for the resistant and recurrent metastatic cancer, ...

$ 4,950.00

Read More

Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017

01 Nov 2017  |  Published by:  DelveInsight
“Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development.  The report covers 20+ companies, which are active in this field with 40+ products and...

$ 2,450.00

Read More
Total 68 records.